{"id":15396,"date":"2021-09-03T09:52:21","date_gmt":"2021-09-03T09:52:21","guid":{"rendered":"https:\/\/clinlabint.com\/?p=15396"},"modified":"2021-09-22T08:15:19","modified_gmt":"2021-09-22T08:15:19","slug":"researchers-make-major-breakthrough-for-tracking-rna-with-fluorescence","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/researchers-make-major-breakthrough-for-tracking-rna-with-fluorescence\/","title":{"rendered":"Researchers make major breakthrough for tracking RNA with fluorescence"},"content":{"rendered":"
\n

\r\n\"Bio-Rad<\/a>\r\n<\/p>\n<\/div><\/section><\/div>

<\/p>\n<\/div><\/section>
\n

Researchers make major breakthrough for tracking RNA with fluorescence<\/h1>\/ in E-News<\/a> <\/span><\/span><\/header>\n<\/div><\/section>
\n

Researchers at Chalmers University of Technology, Sweden, have succeeded in developing a method to label mRNA molecules, and thereby follow, in real time, their path through cells, using a microscope \u2013 without affecting their properties or subsequent activity. The breakthrough could be of great importance in facilitating the development of new RNA-based medicines.<\/h3>\n

<\/p>\n

RNA-based therapeutics offer a range of new opportunities to prevent, treat and potentially cure diseases. But currently, the delivery of RNA therapeutics into the cell is inefficient. For new therapeutics to fulfil their potential, the delivery methods need to be optimised. Now, a new method, recently presented in the Journal of the American Chemical Society, can provide an important piece of the puzzle of overcoming these challenges and take the development a major step forward.<\/p>\n

\u201cSince our method can help solve one of the biggest problems for drug discovery and development, we see that this research can facilitate a paradigm shift from traditional drugs to RNA-based therapeutics,\u201d said Marcus Wilhelmsson, Professor at the Department of Chemistry and Chemical Engineering at Chalmers University of Technology, and one of the main authors of the article.<\/p>\n

The research behind the method has been done in collaboration with chemists and biologists at Chalmers and the biopharmaceuticals company AstraZeneca, through their joint research centre, FoRmulaEx, as well as a research group at the Pasteur Institute, Paris.<\/p>\n

The method involves replacing one of the building blocks of RNA with a fluorescent variant, which, apart from that feature, maintains the natural properties of the original base. The fluorescent units have been developed with the help of a special chemistry, and the researchers have shown that it can then be used to produce messenger RNA (mRNA), without affecting the mRNA\u2019s ability to be translated into a protein at natural speed. This represents a breakthrough which has never before been done successfully. The fluorescence furthermore allows the researchers to follow functional mRNA molecules in real time, seeing how they are taken up into cells with the help of a microscope.<\/p>\n

A challenge when working with mRNA is that the molecules are very large and charged, but at the same time fragile. They cannot get into cells directly and must therefore be packaged. The method that has proven most successful to date uses very small droplets known as lipid nanoparticles to encapsulate the mRNA. There is still a great need to develop new and more efficient lipid nanoparticles \u2013 something which the Chalmers researchers are also working on. To be able to do that, it is necessary to understand how mRNA is taken up into cells. The ability to monitor, in real time, how the lipid nanoparticles and mRNA are distributed through the cell is therefore an important tool.<\/p>\n

\u201cThe great benefit of this method is that we can now easily see where in the cell the delivered mRNA goes, and in which cells the protein is formed, without losing RNA\u2019s natural protein-translating ability,\u201d said Elin Esbj\u00f6rner, Associate Professor at the Department for Biology and Biotechnology and the second lead author of the article.<\/p>\n

\u201cThe great benefit of this method is that we can now easily see where in the cell the delivered mRNA goes, and in waWhen the researchers realised what a difference their method could make and how important the new knowledge is for the field, they made their results available as quickly as possible. Recently, the Royal Swedish Academy of Engineering Sciences (IVA) included the project in its annual 100 list and also highlighted it as particularly important for increasing societal resilience to crises. To ensure useful commercialisation of the method, the researchers have submitted a patent application and are planning for a spin-off company, with the support of the business incubator Chalmers Ventures and the Chalmers Innovation Office.hich cells the protein is formed, without losing RNA\u2019s natural protein-translating ability,\u201d said Elin Esbj\u00f6rner, Associate Professor at the Department for Biology and Biotechnology and the second lead author of the article.<\/p>\n<\/div><\/section>
\n